Clinical Trials
19 trialsNCT00646945 2025-09-16
Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology
Air Liquide Santé International
Phase 4 Completed
NCT00380874 2021-02-11
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Pfizer
Phase 4 Terminated
NCT01982539 2020-05-07
Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute
Depomed
Phase 4 Completed
NCT03176121 2020-03-18
STOP Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT03176199 2020-03-18
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT02287350 2017-07-11
Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain
Depomed
Phase 4 Completed
NCT00171964 2017-06-01
Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions
Novartis
Phase 4 Completed
NCT01315886 2017-04-05
Conversion From Fast Acting Oral Opioids to Abstral®
Orexo AB
Phase 4 Terminated
NCT00434317 2017-02-23
Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT02564107 2016-11-02
A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
Hoffmann-La Roche
Phase 4 Completed
NCT02553707 2015-09-17
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00771199 2014-09-17
An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain
Janssen-Cilag Ltd.
Phase 4 Completed
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated
NCT01006356 2013-08-08
An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT00029224 2012-02-01
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions
Novartis
Phase 4 Completed
NCT00576017 2011-05-19
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).
Janssen-Cilag, S.A.
Phase 4 Completed
NCT00236327 2011-05-17
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
Janssen Cilag S.A.S.
Phase 4 Terminated
NCT00576173 2010-04-28
An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients
Johnson & Johnson Taiwan Ltd
Phase 4 Completed
NCT01060137 2010-02-05
Fentanyl Matrix in Lung Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed